The Industry association biosaxony invites together vfa bio, The VCI e. V. Northeast Regional Association and the Center for Regenerative Therapies Dresden (CRTD) 23. biosaxony on site on the subject "Cutting Edge - Innovations in medicine through cell and gene therapy" am 01 December 2020 welcome. The event takes place virtual instead.
Advanced Therapy Medicinal Products (ATMP) are among the most promising treatment approaches for rare and as yet incurable diseases. In addition to gene therapeutics, ATMP also include cell therapeutics and biotechnologically processed tissue products. They contain either an active ingredient that includes a recombinant nucleic acid or modified cells that replace dysfunctional or defective cells or support processes in diseased tissue to regenerate missing or misdirected functions. In particular, patients suffering from severe hereditary and metabolic diseases, neurodegenerative diseases or cancer have high hopes for these innovative therapies.
The focus of the event is the dialogue between science and industry about the opportunities, risks and special features of cell and gene therapies.
More information and registration can be found here.